Astera Labs (NASDAQ:ALAB) Stock Price Down 1.9% - Should You Sell?

Key Points

• Astera Labs shares fell 1.9% to $382.25, but the stock remains sharply higher year to date, prompting Zacks Research to downgrade it to “Hold” amid valuation, cost and competitive concerns.
• The company posted strong recent results, with quarterly EPS of $0.80 beating estimates and revenue rising 104.5% year over year to $392.4 million. Investors will next focus on its third-quarter 2026 results, scheduled for November 3.
• Analyst sentiment remains broadly positive, with a consensus “Moderate Buy” rating and Fubon setting a $500 price target, although the consensus target is $348.33. Recent insider selling and the stock’s high valuation add risk despite strong AI infrastructure demand.

Shares of Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) fell 1.9% during trading on Wednesday. The company traded as low as $360.22 and last traded at $382.25. 4,990,725 shares changed hands during mid-day trading, a decline of 4% from the average session volume of 5,190,657 shares. The stock had previously closed at $389.80.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Fubon initiated coverage with a $500 price target, signaling meaningful upside potential from current levels and continued confidence in Astera Labs’ role in AI infrastructure connectivity. Fubon starts coverage with USD 500 target for Astera Labs stock
• Positive Sentiment: Recent enthusiasm around AI-related connectivity demand helped drive a sharp rally in ALAB, with coverage highlighting the stock’s strong year-to-date performance and investor interest in its data-center opportunity. ALAB Stock Jumps 7%—Why Astera Labs Is Rallying Today
• Neutral Sentiment: Astera Labs will report third-quarter 2026 financial results after the market closes on November 3, giving investors a near-term catalyst to evaluate demand, margins and forward guidance. Astera Labs Announces Conference Call to Review Third Quarter 2026 Financial Results
• Negative Sentiment: Zacks Research lowered its recommendation to “Hold,” citing the risk-reward balance after ALAB’s 118% year-to-date advance. Analysts also flagged its rich valuation, rising costs and increasing competition, including challenges from Marvell’s partnerships with Nvidia and Microsoft. Should You Buy, Sell, or Hold ALAB Stock After a 118% YTD Rise?

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on ALAB shares. Citigroup reiterated a "buy" rating on shares of Astera Labs in a research note on Wednesday, July 29th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Astera Labs in a report on Tuesday, August 18th. UBS Group reiterated a "neutral" rating and issued a $425.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Stifel Nicolaus raised their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a "buy" rating in a research report on Wednesday, June 24th. Finally, Zacks Research cut shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research note on Monday. Twelve investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, Astera Labs presently has a consensus rating of "Moderate Buy" and an average price target of $348.33.

Astera Labs Trading Down 1.9%

The firm has a market cap of $66.32 billion, a price-to-earnings ratio of 189.23 and a beta of 3.68. The company has a fifty day moving average price of $313.22 and a 200-day moving average price of $286.60.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts' consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company's revenue was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, COO Sanjay Gajendra sold 90,630 shares of the firm's stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief operating officer owned 1,119,038 shares of the company's stock, valued at $380,864,583.30. This trade represents a 7.49% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the transaction, the director directly owned 253,863 shares of the company's stock, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 396,059 shares of company stock worth $122,605,660. Corporate insiders own 10.40% of the company's stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. BlackRock Inc. acquired a new position in shares of Astera Labs during the 2nd quarter worth approximately $6,609,581,000. Bank of America Corp DE acquired a new stake in Astera Labs in the 2nd quarter valued at $1,061,791,000. Atreides Management LP grew its stake in Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after acquiring an additional 1,754,593 shares during the period. Artisan Partners Limited Partnership purchased a new stake in Astera Labs in the 4th quarter worth $148,980,000. Finally, Amundi raised its position in Astera Labs by 77.9% during the first quarter. Amundi now owns 1,880,830 shares of the company's stock worth $206,139,000 after acquiring an additional 823,477 shares during the period. Institutional investors and hedge funds own 60.47% of the company's stock.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.